Founded with a mission to improve patient health globally, Aytu BioPharma, Inc. is a specialty healthcare company that focuses on acquiring, developing, and commercializing innovative products for complex conditions. The company's core areas of expertise include sexual dysfunction disorders, urological cancer, urinary tract infections, male infertility, and ADHD. Aytu BioPharma aims to enhance patient wellness through a diverse portfolio of prescription therapeutics designed to help patients lead healthier and more fulfilling lives.
Aytu BioPharma has garnered attention for its impactful contributions to healthcare, supported by a team of dedicated professionals and strategic investors. The company has achieved significant milestones in advancing treatments for ADHD and urological disorders, reflecting its commitment to addressing unmet medical needs. Through its innovative therapies and global reach, Aytu BioPharma continues to make a substantial impact on patient care and the broader healthcare landscape.
